Axsome Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:AXSM) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -43.38 M-32.42 M1.05 M-18.65 M-20.7 M -70.73 M Cash from investing activities -338 K-13 K-58 K-71 K-121 K -263 K Cash from financing activities 29.27 M34.54 M21.27 M16.39 M2.99 M 75.19 M Free cash flow -43.38 M-32.42 M1.05 M-18.65 M-20.7 M -70.73 M

News

Apple Shines As It Nears Fresh High, Leads 18 Hot Picks Onto Best Stock Lists

Dow Jones Futures: Oil Spikes On Iran News, But Nvidia, Valero, Dell Rise; SpaceX Hits New Low

Axsome Begins Phase III Study on Solriamfetol for ADHD in Children

Axsome Therapeutics, Exelixis, Incyte Among 20 New Stocks On IBD's Premier Watchlists

Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline

Flash Memory Chipmaker Sandisk Hits Record High, Leads 18 Onto Best Growth Stock Lists

Amphenol Pops 7%, Leads 20 Hot Stocks Onto Top Performer Lists Like Big Cap 20

Axsome Therapeutics, Inc. (AXSM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

No. 1 Rated Drugmaker Lilly Hits Record High, Leads 18 Onto Best Growth Stock Lists

Why Is Mirum Pharmaceuticals (MIRM) Down 10.1% Since Last Earnings Report?

Why Is Ocugen (OCGN) Down 10.7% Since Last Earnings Report?

Caterpillar Plows Ahead, Hits Fresh High. Leads 19 Top Performers To Best Stock Lists.